Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

Vmn1r1 Inhibitors

Vmn1r1, a member of the vomeronasal receptor family, is a crucial molecular player in the intricate system of chemical communication that governs social behaviors in various species. Primarily expressed in the vomeronasal organ, this receptor serves as a specialized detector of pheromones-biochemical substances that convey important information about an organism's reproductive status, social hierarchy, and territorial boundaries. The functional significance of Vmn1r1 lies in its ability to recognize and transduce these chemical cues, triggering specific neural responses that modulate innate behaviors essential for species survival. The primary function of Vmn1r1 involves the detection of pheromones, which are vital for mediating social behaviors such as mating rituals, territorial marking, and hierarchical interactions. As part of the vomeronasal sensory system, Vmn1r1 responds to diverse chemical stimuli, translating them into neural signals that influence instinctive behaviors critical for reproductive success and social cohesion. This receptor plays an integral role in the communication between conspecifics, allowing organisms to respond appropriately to chemical cues in their environment. The specificity of Vmn1r1 in recognizing particular pheromones underscores its importance in shaping social dynamics and facilitating crucial aspects of species-specific behavior.

Inhibition of Vmn1r1 involves intricate signaling pathways and molecular mechanisms that indirectly modulate its function. Chemical compounds targeting key cellular pathways, such as VEGF signaling, MAPK cascades, and PI3K-Akt pathways, exert their influence on Vmn1r1 by disrupting downstream signaling events associated with the receptor. Inhibition may occur through the interference with tyrosine kinases, SRC kinases, or other intracellular mediators that are part of the broader signaling network implicated in vomeronasal receptor function. These pathways, once perturbed by specific inhibitors, may alter cellular processes related to Vmn1r1 activity, impacting its ability to transduce pheromone signals and, consequently, modifying innate behavioral responses. Understanding these indirect mechanisms of inhibition provides insights into the regulatory complexity of vomeronasal receptor function and the intricate interplay between chemical signaling and behavior in the animal kingdom.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Dasatinib

302962-49-8sc-358114
sc-358114A
25 mg
1 g
$70.00
$145.00
51
(1)

SRC kinase inhibitor affecting cellular signaling cascades. Dasatinib inhibits SRC kinases, indirectly impacting Vmn1r1 by interfering with downstream signaling pathways associated with cellular processes relevant to vomeronasal receptor function.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

p38 MAPK inhibitor affecting MAPK signaling pathways. SB203580 inhibits p38 MAPK, indirectly influencing Vmn1r1 through modulation of MAPK signaling cascades, potentially altering cellular processes related to vomeronasal receptor function.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

PI3K inhibitor affecting PI3K-Akt signaling. Wortmannin inhibits PI3K, indirectly influencing Vmn1r1 by disrupting the PI3K-Akt pathway and potentially modulating cellular processes associated with vomeronasal receptor function.

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$186.00
$707.00
88
(1)

ROCK inhibitor affecting cytoskeletal dynamics. Y-27632 inhibits ROCK, indirectly influencing Vmn1r1 by modulating cytoskeletal dynamics, potentially altering cellular processes relevant to vomeronasal receptor function.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

JNK inhibitor affecting the MAPK signaling pathway. SP600125 inhibits JNK, indirectly influencing Vmn1r1 through modulation of the MAPK signaling pathway, potentially altering cellular processes relevant to vomeronasal receptor function.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

PI3K inhibitor affecting PI3K-Akt signaling. LY294002 inhibits PI3K, indirectly influencing Vmn1r1 by disrupting the PI3K-Akt pathway and potentially modulating cellular processes associated with vomeronasal receptor function.

PP 2

172889-27-9sc-202769
sc-202769A
1 mg
5 mg
$94.00
$227.00
30
(1)

SRC kinase inhibitor affecting cellular signaling cascades. PP2 inhibits SRC kinases, indirectly impacting Vmn1r1 by interfering with downstream signaling pathways associated with cellular processes relevant to vomeronasal receptor function.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

MEK inhibitor affecting the MAPK signaling pathway. PD98059 inhibits MEK, indirectly influencing Vmn1r1 by disrupting the MAPK signaling pathway, potentially modulating cellular processes associated with vomeronasal receptor function.

SB 202190

152121-30-7sc-202334
sc-202334A
sc-202334B
1 mg
5 mg
25 mg
$31.00
$128.00
$454.00
45
(1)

p38 MAPK inhibitor affecting MAPK signaling pathways. SB202190 inhibits p38 MAPK, indirectly influencing Vmn1r1 through modulation of MAPK signaling cascades, potentially altering cellular processes relevant to vomeronasal receptor function.

BKM120

944396-07-0sc-364437
sc-364437A
sc-364437B
sc-364437C
5 mg
10 mg
25 mg
50 mg
$176.00
$235.00
$281.00
$339.00
9
(0)

PI3K inhibitor affecting PI3K-Akt signaling. BKM120 inhibits PI3K, indirectly influencing Vmn1r1 by disrupting the PI3K-Akt pathway and potentially modulating cellular processes associated with vomeronasal receptor function.